CollPlant (NASDAQ: CLGN) (TASE:CLGN), a regenerative medicine company utilising its proprietary plant-based rhCollagen (recombinant human collagen) technology for tissue repair products, announced yesterday that it has added Shay Soker, Professor at the Wake Forest Institute for Regenerative Medicine, to its Scientific Advisory Board.

Professor Soker brings more than 25 years of expertise in the areas of tissue engineering, stem cells, tissue scaffolds, cell differentiation and bioengineering to CollPlant. He presently serves as professor of Regenerative Medicine and the scientific officer for WFIRM. Prof Soker is an affiliated professor of Cancer Biology, Physiology & Pharmacology, Biomedical Engineering and Surgical Sciences at the Wake Forest School of Medicine.

Yehiel Tal, chief executive officer of CollPlant, said, 'Shay is a highly regarded and widely published authority in the field of regenerative medicine, and we are delighted to add someone of his calibre to an already world-class Scientific Advisory Board. We believe Shay's expertise in tissue engineering will prove invaluable to the leadership team, and we look forward to his insights and guidance as we work to advance development of our lead program, rhCollagen-based BioInks, for the 3D bioprinting of tissues and organs.'